Interpersonal Factors in the Pharmacokinetics and Pharmacodynamics of Voriconazole: Are CYP2C19 Genotypes Enough for Us to Make a Clinical Decision?

BACKGROUND: Invasive mycoses are serious infections with high mortality and increasing inci-dence. Voriconazole, an important drug to treat invasive mycosis, is metabolized mainly by the cytochrome P450 family 2 subfamily C member 19 enzyme (CYP2C19) and is affected by the genotypes of CYP2C19. OBJE...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhong, Xuefeng, Tong, Xunliang, Ju, Yang, Du, Xiaoman, Li, Yanming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6635675/
https://www.ncbi.nlm.nih.gov/pubmed/29361899
http://dx.doi.org/10.2174/1389200219666171227200547

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6635675/
https://www.ncbi.nlm.nih.gov/pubmed/29361899
http://dx.doi.org/10.2174/1389200219666171227200547

Ejemplares similares